The regulation of protein phosphatase 4 by FBXO42 is required for cancer cell survival

Stephan H Spangenberg1,2, Nicholas Garaffo3,4, Enya Marie Catherine Alcindor1,2

  • 1Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.

EMBO Reports
|July 14, 2026
PubMed

Insights

FBXO42 and CCDC6 independently regulate protein phosphatase 4 (PPP4C). Aberrant PPP4C activation drives cell death when FBXO42 or CCDC6 is compromised, revealing their distinct roles in cancer cell viability.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • FBXO42 is an F-box protein crucial for numerous cancer cell lines.
  • FBXO42's functional correlation with CCDC6 suggests a shared pathway, but their precise relationship is unclear.

Purpose of the Study:

  • To elucidate the functional relationship between FBXO42, CCDC6, and protein phosphatase 4 (PPP4C).
  • To understand the distinct mechanisms by which FBXO42 and CCDC6 regulate PPP4C.

Main Methods:

  • Co-immunoprecipitation assays to confirm protein interactions.
  • Ubiquitination assays to assess FBXO42's effect on PPP4C.
  • siRNA-mediated knockdown to evaluate cellular viability.

Main Results:

  • FBXO42 directly ubiquitinates and negatively regulates PPP4C.
  • FBXO42 and CCDC6 bind to PPP4C independently, indicating separate regulatory mechanisms.
  • Knockdown of PPP4C rescues cell viability in FBXO42/CCDC6-dependent glioblastoma cells.

Conclusions:

  • FBXO42 and CCDC6 independently regulate PPP4C through distinct mechanisms.
  • Aberrant PPP4C activation contributes to cell death when FBXO42 or CCDC6 function is impaired.
  • These findings provide mechanistic insight into the FBXO42-CCDC6-PPP4C axis in cancer cell biology.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...